Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer

NCT01525589 is registered in ClinicalTrials.gov with PharmaMar as lead sponsor.

NCT NCT01525589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01525589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer
Lead sponsor
PharmaMar
Phase
Phase 2
Overall status
Completed
Start date
June 13, 2012
Completion date
October 31, 2018
Enrollment
111 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer